Co-Authors
This is a "connection" page, showing publications co-authored by Nicole Pilch and James Fleming.
Connection Strength
1.575
-
Wise B, Wilson LZ, Taber DJ, Pilch NA, Rohan V, Fleming JN. The impact of pretransplant opioid exposure on healthcare utilization and costs in kidney transplant. Pharmacotherapy. 2021 01; 41(1):6-13.
Score: 0.215
-
Rohan VS, Taber DJ, Patel N, Perez C, Pilch N, Parks S, Bolin E, Nadig SN, Baliga PK, Fleming JN. Impact of a multidisciplinary multimodal opioid minimization initiative in kidney transplant recipients. Clin Transplant. 2020 10; 34(10):e14006.
Score: 0.212
-
Taber DJ, Pilch NA, McGillicuddy JW, Mardis C, Treiber F, Fleming JN. Using informatics and mobile health to improve medication safety monitoring in kidney transplant recipients. Am J Health Syst Pharm. 2019 Jul 18; 76(15):1143-1149.
Score: 0.196
-
Pilch NA, Fleming JN, Crowther BR, Maldonado AQ, Taber DJ. It is time for board certification in transplant pharmacotherapy. Am J Transplant. 2018 09; 18(9):2370-2371.
Score: 0.182
-
Fleming JN, Taber DJ, Pilch NA, Mardis CR, Gilbert RE, Wilson LZ, Patel N, Ball S, Mauldin P, Baliga PK. Association of Pretransplantion Opioid Use with Graft Loss or Death in Liver Transplantation Patients with Model of End-Stage Liver Disease Exceptions. J Am Coll Surg. 2018 04; 226(4):651-659.
Score: 0.176
-
Casale JP, Taber DJ, Staino C, Boyle K, Covert K, Pilch NA, Mardis C, Meadows HB, Chavin KD, McGillicuddy JW, Baliga PK, Fleming JN. Effectiveness of an Evidence-Based Induction Therapy Protocol Revision in Adult Kidney Transplant Recipients. Pharmacotherapy. 2017 Jun; 37(6):692-699.
Score: 0.169
-
Fleming JN, Taber DJ, Pilch NA, McGillicuddy JW, Srinivas TR, Baliga PK, Chavin KD, Bratton CF. A randomized, prospective comparison of transition to sirolimus-based CNI-minimization or withdrawal in African American kidney transplant recipients. Clin Transplant. 2016 05; 30(5):528-33.
Score: 0.155
-
Taber DJ, Su Z, Fleming JN, Pilch NA, Morinelli T, Mauldin P, Dubay D. The impact of time-varying clinical surrogates on disparities in African-American kidney transplant recipients - a retrospective longitudinal cohort study. Transpl Int. 2019 01; 32(1):84-94.
Score: 0.046
-
Veasey TM, Fleming JN, Strout SE, Miller R, Pilch NA, Meadows HB, Mardis CR, Mardis BA, Shenvi S, McGillicuddy J, Chavin KD, Baliga P, Taber DJ. Morbid obesity and functional status as predictors of surgical complication after renal transplantation. Am J Surg. 2018 Apr; 215(4):663-668.
Score: 0.042
-
Covert KL, Mardis CR, Fleming JN, Pilch NA, Meadows HB, Mardis BA, Mohan P, Posadas-Salas M, Srinivas T, Taber DJ. Development of a Predictive Model for Drug-Related Problems in Kidney Transplant Recipients. Pharmacotherapy. 2017 02; 37(2):159-169.
Score: 0.041
-
Covert KL, Fleming JN, Staino C, Casale JP, Boyle KM, Pilch NA, Meadows HB, Mardis CR, McGillicuddy JW, Nadig S, Bratton CF, Chavin KD, Baliga PK, Taber DJ. Predicting and preventing readmissions in kidney transplant recipients. Clin Transplant. 2016 07; 30(7):779-86.
Score: 0.039
-
Morbitzer KA, Taber DJ, Pilch NA, Meadows HB, Fleming JN, Bratton CF, McGillicuddy JW, Baliga PK, Chavin KD. The impact of diabetes mellitus and glycemic control on clinical outcomes following liver transplant for hepatitis C. Clin Transplant. 2014 Aug; 28(8):862-8.
Score: 0.034
-
Taber DJ, Spivey JR, Tsurutis VM, Pilch NA, Meadows HB, Fleming JN, McGillicuddy JW, Bratton CF, Treiber FA, Baliga PK, Chavin KD. Clinical and economic outcomes associated with medication errors in kidney transplantation. Clin J Am Soc Nephrol. 2014 May; 9(5):960-6.
Score: 0.034
-
Taber DJ, Srinivas TM, Pilch NA, Meadows HB, Fleming JN, McGillicuddy JW, Bratton CF, Thomas B, Chavin KD, Baliga PK, Egede LE. Are thiazide diuretics safe and effective antihypertensive therapy in kidney transplant recipients? Am J Nephrol. 2013; 38(4):285-91.
Score: 0.033